Santersus AG Receives Second US FDA Breakthrough Device Designation for NucleoCapture in Systemic Lupus Erythematosus

Zurich, Switzerland, 26th Aug 2025 — Santersus AG today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to its NucleoCapture(tm) blood purification technology for the treatment of severe, treatment-refractory systemic lupus erythematosus (SLE). This […]

Read more

The Launch Press Conference of the 6th Lushan International Romance Film Week Held, Activating a New Business Model of “Movie and Tourism Integration”

Beijing, China – On August 21, the Launch Press Conference of the 6th Lushan International Romance Film Week, themed “Green Wild Love Letter, Cinematic Lushan”, was held in Beijing. As a cultural brand carefully crafted by Lushan City, the Lushan International […]

Read more
1 404 405 406 407 408 494